Intraovarian tumor necrosis factor-related weak inducer of apoptosis/fibroblast growth factor-inducible-14 ligand-receptor system limits ovarian preovulatory follicles from excessive luteinization

Molecular Endocrinology

Volumn 20, Issue 10, 2006, Pages 2528-2538

  De, Ananya ^a   Park, Jae Il ^a   Kawamura, Kazuhiro ^a   Chen, Ruby ^a   Klein, Cynthia ^a   Rauch, Rami ^a   Mulders, Sabine M ^b   Gelpke, Maarten D Sollewijn ^b   Hsueh, Aaron J W ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NV ORGANON   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INDUCING FACTOR; CHORIONIC GONADOTROPIN; CYCLIC AMP; FIBROBLAST GROWTH FACTOR RECEPTOR; GONADOTROPIN; LIGAND; LUTEINIZING HORMONE; PROGESTERONE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GRANULOSA CELL; IN SITU HYBRIDIZATION; LUTEINIZATION; NONHUMAN; OOCYTE MATURATION; OVARY CELL; OVARY FOLLICLE; OVULATION; PARACRINE SIGNALING; PRIORITY JOURNAL; PROGESTERONE SYNTHESIS; PROTEIN EXPRESSION; RAT; STEROIDOGENESIS; THECA CELL;

ANIMALS; BLOTTING, WESTERN; CHORIONIC GONADOTROPIN; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION; IN SITU HYBRIDIZATION; LUTEINIZATION; MICROARRAY ANALYSIS; OVARIAN FOLLICLE; OVARY; PROGESTERONE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TUMOR NECROSIS FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THECA CELLS; TUMOR NECROSIS FACTORS;

EID: 33749324164     PISSN: 08888809     EISSN: 08888809     Source Type: Journal    
DOI: 10.1210/me.2006-0028     Document Type: Article

References (48)

1. Hsueh AJ, Adashi EY, Jones PB, Welsh Jr TH 1984 Hormonal regulation of the differentiation of cultured ovarian granulosa cells. Endocr Rev 5:76-127
2. Richards JS 1994 Hormonal control of gene expression in the ovary. Endocr Rev 15:725-751
3. Espey LL 1994 Current status of the hypothesis that mammalian ovulation is comparable to an inflammatory reaction. Biol Reprod 50:233-238
4. Adashi EY, Resnick CE, D'Ercole AJ, Svoboda ME, Van Wyk JJ 1985 Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function. Endocr Rev 6:400-420
5. Park JY, Su YQ, Ariga M, Law E, Jin SL, Conti M 2004 EGF-like growth factors as mediators of LH action in the ovulatory follicle. Science 303:682-684
6. Ashkenazi H, Cao X, Motola S, Popliker M, Conti M, Tsafriri A 2005 Epidermal growth factor family members: endogenous mediators of the ovulatory response. Endocrinology 146:77-84
7. Kawamura K, Kumagai J, Sudo S, Chun SY, Pisarska M, Morita H, Toppari J, Fu P, Wade JD, Bathgate RA, Hsueh AJ 2004 Paracrine regulation of mammalian oocyte maturation and male germ cell survival. Proc Natl Acad Sci USA 101:7323-7328
8. Kawamura K, Kawamura N, Mulders SM, Sollewijn Gelpke MD, Hsueh AJ 2005 Ovarian brain-derived neurotrophic factor (BDNF) promotes the development of oocytes into preimplantation embryos. Proc Natl Acad Sci USA 102:9206-9211
9. Neulen J, Raczek S, Pogorzelski M, Grunwald K, Yeo TK, Dvorak HF, Weich HA, Breckwoldt M 1998 Secretion of vascular endothelial growth factor/vascular permeability factor from human luteinized granulosa cells is human chorionic gonadotropin dependent. Mol Hum Reprod 4:203-206
10. Zachow RJ, Tash JS, Terranova PF 1993 Tumor necrosis factor-α attenuation of luteinizing hormone-stimulated androstenedione production by ovarian theca-interstitial cells: inhibition at loci within the adenosine 3′,5′-monophosphate-dependent signaling pathway. Endocrinology 133:2269-2276
11. Hernandez ER, Hurwitz A, Payne DW, Dharmarajan AM, Purchio AF, Adashi EY 1990 Transforming growth factor-β 1 inhibits ovarian androgen production: gene expression, cellular localization, mechanisms (s), and site (s) of action. Endocrinology 127:2804-2811
12. Shimasaki S, Zachow RJ, Li D, Kim H, Iemura S, Ueno N, Sampath K, Chang RJ, Erickson GF 1999 A functional bone morphogenetic protein system in the ovary. Proc Natl Acad Sci USA 96:7282-7287
13. Glister C, Richards SL, Knight PG 2005 Bone morphogenetic proteins (BMP) -4, -6, and -7 potently suppress basal and luteinizing hormone-induced androgen production by bovine theca interna cells in primary culture: could ovarian hyperandrogenic dysfunction be caused by a defect in thecal BMP signaling? Endocrinology 146:1883-1892
14. Locksley RM, Killeen N, Lenardo MJ 2001 The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104:487-501
15. Bodmer JL, Schneider P, Tschopp J 2002 The molecular architecture of the TNF superfamily. Trends Biochem Sci 27:19-26
16. Chicheportiche Y, Bourdon PR, Xu H, Hsu YM, Scott H, Hession C, Garcia I, Browning JL 1997 TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem 272:32401-32410
17. Phillips TA, Ni J, Hunt JS 2001 Death-inducing tumour necrosis factor (TNF) superfamily ligands and receptors are transcribed in human placentae, cytotrophoblasts, placental macrophages and placental cell lines. Placenta 22:663-672
18. Brown SA, Richards CM, Hanscom HN, Feng SL, Winkles JA 2003 The Fn14 cytoplasmic tail binds tumour-necrosis-factor-receptor-associated factors 1, 2, 3 and 5 and mediates nuclear factor-κB activation. Biochem J 371:395-403
19. Polavarapu R, Gongora MC, Winkles JA, Yepes M 2005 Tumor necrosis factor-like weak inducer of apoptosis increases the permeability of the neurovascular unit through nuclear factor-κB pathway activation. J Neurosci 25:10094-10100
20. Saitoh T, Nakayama M, Nakano H, Yagita H, Yamamoto N, Yamaoka S 2003 TWEAK induces NF-κB2 p100 processing and long lasting NF-κB activation. J Biol Chem 278:36005-36012
21. Tran NL, McDonough WS, Savitch BA, Sawyer TF, Winkles JA, Berens ME 2005 The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFκB pathway activation and BCL-XL/BCL-W expression. J Biol Chem 280:3483-3492
22. Meighan-Mantha RL, Hsu DK, Guo Y, Brown SA, Feng SL, Peifley KA, Alberts GF, Copeland NG, Gilbert DJ, Jenkins NA, Richards CM, Winkles JA 1999 The mitogen-inducible Fn14 gene encodes a type I transmembrane protein that modulates fibroblast adhesion and migration. J Biol Chem 274:33166-33176
23. Feng SL, Guo Y, Factor VM, Thorgeirsson SS, Bell DW, Testa JR, Peifley KA, Winkles JA 2000 The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas. Am J Pathol 156:1253-1261
24. Lynch CN, Wang YC, Lund JK, Chen YW, Leal JA, Wiley SR 1999 TWEAK induces angiogenesis and proliferation of endothelial cells. J Biol Chem 274:8455-8459
25. Wiley SR, Cassiano L, Lofton T, Davis-Smith T, Winkles JA, Lindner V, Liu H, Daniel TO, Smith CA, Fanslow WC 2001 A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis. Immunity 15:837-846
26. Ho DH, Vu H, Brown SA, Donohue PJ, Hanscom HN, Winkles JA 2004 Soluble tumor necrosis factor-like weak inducer of apoptosis overexpression in HEK293 cells promotes tumor growth and angiogenesis in athymic nude mice. Cancer Res 64:8968-8972
27. Campbell S, Michaelson J, Burkly L, Putterman C 2004 The role of TWEAK/Fn14 In the pathogenesis of inflammation and systemic autoimmunity. Front Biosci 9:2273-2284
28. Chicheportiche Y, Chicheportiche R, Sizing I, Thompson J, Benjamin CB, Ambrose C, Dayer JM 2002 Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies. Arthritis Res 4:126-133
29. Saas P, Boucraut J, Walker PR, Quiquerez AL, Billot M, Desplat-Jego S, Chicheportiche Y, Dietrich PY 2000 TWEAK stimulation of astrocytes and the proinflammatory consequences. Glia 32:102-107
30. Mueller AM, Pedre X, Kleiter I, Hornberg M, Steinbrecher A, Giegerich G 2005 Targeting fibroblast growth factor-inducible-14 signaling protects from chronic relapsing experimental autoimmune encephalomyelitis. J Neuroimmunol 159:55-65
31. Jakubowski A, Ambrose C, Parr M, Lincecum JM, Wang MZ, Zheng TS, Browning B, Michaelson JS, Baestcher M, Wang B, Bissell DM, Burkly LC 2005 TWEAK induces liver progenitor cell proliferation. J Clin Invest 115:2330-2340
32. Tran NL, McDonough WS, Donohue PJ, Winkles JA, Berens TJ, Ross KR, Hoelzinger DB, Beaudry C, Coons SW, Berens ME 2003 The human Fn14 receptor gene is up-regulated in migrating glioma cells in vitro and overexpressed in advanced glial tumors. Am J Pathol 162:1313-1321
33. Michaelson JS, Cho S, Browning B, Zheng TS, Lincecum JM, Wang MZ, Hsu YM, Burkly LC 2005 TWEAK induces mammary epithelial branching morphogenesis. Oncogene 24:2613-2624
34. Yepes M, Brown SA, Moore EG, Smith EP, Lawrence DA, Winkles JA 2005 A soluble Fn14-Fc decoy receptor reduces infarct volume in a murine model of cerebral ischemia. Am J Pathol 166:511-520
35. Donohue PJ, Richards CM, Brown SA, Hanscom HN, Buschman J, Thangada S, Hla T, Williams MS, Winkles JA 2003 TWEAK is an endothelial cell growth and chemotactic factor that also potentiates FGF-2 and VEGF-A mitogenic activity. Arterioscler Thromb Vasc Biol 23:594-600
36. Nakayama M, Kayagaki N, Yamaguchi N, Okumura K, Yagita H 2000 Involvement of TWEAK in interferon γ-stimulated monocyte cytotoxicity. J Exp Med 192:1373-1380
37. Vitt UA, Hayashi M, Klein C, Hsueh AJ 2000 Growth differentiation factor-9 stimulates proliferation but suppresses the follicle-stimulating hormone-induced differentiation of cultured granulosa cells from small antral and preovulatory rat follicles. Biol Reprod 62:370-377
38. Otsuka F, Yao Z, Lee T, Yamamoto S, Erickson GF, Shimasaki S 2000 Bone morphogenetic protein-15. Identification of target cells and biological functions. J Biol Chem 275:39523-39528
39. Hinckley ST, Milvae RA 2001 Endothelin-1 mediates prostaglandin F(2α)-induced luteal regression in the ewe. Biol Reprod 64:1619-1623
40. Falck B 1959 Site of production of oestrogen in rat ovary as studied by microtransplants. Acta Physiol Scand 47:1-101
41. Terranova PF, Rice VM 1997 Review: cytokine involvement in ovarian processes. Am J Reprod Immunol 37:50-63
42. Adashi EY, Resnick CE, Packman JN, Hurwitz A, Payne DW 1990 Cytokine-mediated regulation of ovarian function: tumor necrosis factor α inhibits gonadotropin-supported progesterone accumulation by differentiating and luteinized murine granulosa cells. Am J Obstet Gynecol 162:889-896; discussion 896-899
43. Roby KF, Son DS, Terranova PF 1999 Alterations of events related to ovarian function in tumor necrosis factor receptor type I knockout mice. Biol Reprod 61:1616-1621
44. Spicer LJ 2001 Receptors for insulin-like growth factor-I and tumor necrosis factor-α are hormonally regulated in bovine granulosa and thecal cells. Anim Reprod Sci 67:45-58
45. Delbaere A, Bergmann PJ, Gervy-Decoster C, Deschodt-Lanckman M, de Maertelaer V, Staroukine M, Camus M, Englert Y 1997 Increased angiotensin II in ascites during severe ovarian hyperstimulation syndrome: role of early pregnancy and ovarian gonadotropin stimulation. Fertil Steril 67:1038-1045
46. Elchalal U, Schenker JG 1997 The pathophysiology of ovarian hyperstimulation syndrome - views and ideas. Hum Reprod 12:1129-1137
47. Luo CW, Kawamura K, Klein C, Hsueh AJ 2004 Paracrine regulation of ovarian granulosa cell differentiation by stanniocalcin (STC) 1: mediation through specific STC1 receptors. Mol Endocrinol 18:2085-2096
48. Chun SY, Billig H, Tilly JL, Furuta I, Tsafriri A, Hsueh AJ 1994 Gonadotropin suppression of apoptosis in cultured preovulatory follicles: mediatory role of endogenous insulin-like growth factor I. Endocrinology 135:1845-1853